RecruitingNot ApplicableNCT07006142
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
Sponsor
Mayo Clinic
Enrollment
150 participants
Start Date
Aug 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients undergoing elective upper endoscopy with gastroenterology team
Exclusion Criteria9
- Urgent or emergent procedure
- Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
- Upper GI barium study performed in past 24 hours.
- Gastroparesis
- Achalasia
- Pancreatitis
- Use of outpatient pro-motility medications
- Patient refusal
- Inability for patient to provide own consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERModified Fasting Guidelines
Patients will follow a full-liquid diet 48 hours prior to their procedure, clear liquid diet 24 hours prior to their procedure, and nothing by mouth (NPO) after midnight on the day of their procedure
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07006142